Last reviewed · How we verify
Systemic Lupus Erythematosus (SLE)
Approved treatments
- Solu-Cortef · Pfizer
- Hydroxychloroquine Sulfate · Sanofi
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases. - Imuran · Legacy Pharma
- Cortifoam · Pfizer
- Intrarosa
- Cortone
- Lymphostat B · Human Genome Sciences Inc.
Belimumab works by blocking the B Lymphocyte Stimulator, a protein that can contribute to the autoimmune response in Systemic lupus erythematosus. - Celestone Soluspan
- Decadron · Generic (originally Merck)
- Benlysta · GlaxoSmithKline
- prednison · Wen Zhang
- Intrarosa · Center for Vulvovaginal Disorders
- Medrol · Generic (originally Upjohn/Pfizer)
Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions. - Cortef · Generic (originally Merck/Upjohn)
- Rodinolone
- Deltasone · Generic (originally Schering)
- Oral [14C] PF-06821497 · Pfizer
- Aralen · Sanofi
Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death. - Hydroxychloroquine Sulfate · Advanz
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body. - Betametasone
Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system. - Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
- Methylprednisolon · Leiden University Medical Center
- Hydroxychloroquin · Children's Hospital of Fudan University
- Dehydroepiandrosterone · National Institute of Dental and Craniofacial Research (NIDCR)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Systemic Lupus Erythematosus (SLE) patent landscape — cliff calendar, originator estates, attackable patents
- Systemic Lupus Erythematosus (SLE) treatment landscape brief
- Systemic Lupus Erythematosus (SLE) treatment updates RSS
Frequently asked questions about Systemic Lupus Erythematosus (SLE)
What drugs treat Systemic Lupus Erythematosus (SLE)?
Tracked treatments include Solu-Cortef, Hydroxychloroquine Sulfate, Imuran, Cortifoam, Intrarosa, Cortone, Lymphostat B, Celestone Soluspan.
What is the treatment for Systemic Lupus Erythematosus (SLE)?
Standard treatment for Systemic Lupus Erythematosus (SLE) includes Solu-Cortef, Hydroxychloroquine Sulfate, Imuran, Cortifoam, Intrarosa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Therapeutic area: All conditions in Immunology & Inflammation
- Treatment landscape: Systemic Lupus Erythematosus (SLE) patent cliff · Systemic Lupus Erythematosus (SLE) CI report
- Treatment: Solu-Cortef · Pfizer
- Treatment: Hydroxychloroquine Sulfate · Sanofi
- Treatment: Imuran · Legacy Pharma
- Treatment: Cortifoam · Pfizer
- Treatment: Intrarosa
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing